Follicum
Founded Year
2011Stage
Acquired | AcquiredTotal Raised
$1.49MAbout Follicum
Follicum is an early-stage biopharmaceutical company focusing on developing novel therapeutics for the management of hair growth.On March 1st, 2022, Follicum was acquired by Coegin Pharma. The terms of the transaction were not disclosed.
Follicum Headquarter Location
Scheelevagen 22
Lund, 223 63,
Sweden
+46 (0)46 19 21 97
Expert Collections containing Follicum
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Follicum is included in 2 Expert Collections, including Biopharma Tech.
Biopharma Tech
15,535 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Advanced Materials
1,246 items
Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.
Follicum Patents
Follicum has filed 6 patents.
The 3 most popular patent topics include:
- Autosomal recessive disorders
- Diabetes
- Insulin therapies
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/29/2019 | 10/27/2020 | Diabetes, Autosomal recessive disorders, Rare diseases, Peptide hormones, Insulin therapies | Grant |
Application Date | 10/29/2019 |
|---|---|
Grant Date | 10/27/2020 |
Title | |
Related Topics | Diabetes, Autosomal recessive disorders, Rare diseases, Peptide hormones, Insulin therapies |
Status | Grant |
Latest Follicum News
Sep 22, 2021
Suggested merge of Follicum and Coegin Pharma Search for content, post, videos The boards of Coegin Pharma and Follicum have assumed a merger plan in order to implement a merger of Coegin Pharma and Follicum through a limited company legal fusion.The fusion will be implemented by Follicum being absorbed by Coegin Pharma.Read more: Follicum pauses all of its development Already a subscriber Login You have read all your free articles, to continue reading subscribe to read the rest of this content. August 18, 2021 Alligator Bioscience has entered into a research collaboration and license agreement with Orion Corporation to discover and develop together new bispecific antibody cancer therapeutics. The research collaboration will focus on the discovery of novel bispecific antibodies directed towards immuno-oAlready a subscriber Login You have read all your free articles, to… January 31, 2020 Aprea Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for APR-246 in combination with azacitidine for the treatment of myelodysplastic syndromes (MDS) with a susceptible TP53 mutation. MDS represents a spectrum of hematopoieAlready a subscriber Login You have read all your free… June 9, 2017 AstraZeneca has entered an agreement with Grünenthal for the global rights to Zomig (zolmitriptan) outside Japan. Zomig is indicated for the acute treatment of migraines and cluster headaches, an area of medicine outside AstraZeneca’s strategic focus. Grünenthal will pay AstraZeneca $200 Already a subscriber Login You have read all your free…
Follicum Web Traffic
Follicum Rank
When was Follicum founded?
Follicum was founded in 2011.
Where is Follicum's headquarters?
Follicum's headquarters is located at Scheelevagen 22, Lund.
What is Follicum's latest funding round?
Follicum's latest funding round is Acquired.
How much did Follicum raise?
Follicum raised a total of $1.49M.
Who are the investors of Follicum?
Investors of Follicum include Coegin Pharma, Vinnova, Eurostars Programme and Sunstone Capital.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.